For example, isocitrate dehydrogenase (IDH)-mutant gliomas are associated with greater contralesional grey matter volume,8 and fewer reductions in whole brain FC when compared with IDH-wildtype tumors.9 Both patterns suggest that IDH-mutation status modulates reorganization. This evidence concerns the gene IDH3A and central nervous system cancer.